Safety and efficacy of a GLP-1 and glucagon receptor dual agonist mazdutide (IBI362) 9 mg and 10 mg in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple-ascending-dose phase 1b trial
Titel:
Safety and efficacy of a GLP-1 and glucagon receptor dual agonist mazdutide (IBI362) 9 mg and 10 mg in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple-ascending-dose phase 1b trial
Auteur:
Ji, Linong Gao, Leili Jiang, Hongwei Yang, Jing Yu, Lei Wen, Jie Cai, Chenghang Deng, Huan Feng, Liqi Song, Baili Ma, Qingyang Qian, Lei